2019
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Inflammatory Biomarkers in Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV), and HIV/HCV Coinfection
Hanberg JS, Freiberg MS, Goetz MB, Rodriguez-Barradas MC, Gibert C, Oursler KA, Justice AC, Tate JP. Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Inflammatory Biomarkers in Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV), and HIV/HCV Coinfection. Open Forum Infectious Diseases 2019, 6: ofz347. PMID: 31660334, PMCID: PMC6786514, DOI: 10.1093/ofid/ofz347.Peer-Reviewed Original ResearchHuman immunodeficiency virusVACS Index 2.0Veterans Aging Cohort StudyAddition of NLRHepatic decompensationLymphocyte ratioHepatitis C virusInflammatory biomarkersImmunodeficiency virusHepatitis C virus statusHIV/HCV coinfectionC virus statusPrognostic inflammatory biomarkerSoluble CD-14Strong unadjusted associationsAging Cohort StudyBiomarkers of inflammationPoor health outcomesMortality risk indexHCV coinfectionAntiretroviral therapyCohort studyBiomarker cohortD-dimerPrognostic index
2013
Viral status at the time of liver transplantation for hepatocellular carcinoma: a modern predictor of longterm survival
Groeschl R, Hong J, Christians K, Turaga K, Tsai S, Pilgrim C, Gamblin T. Viral status at the time of liver transplantation for hepatocellular carcinoma: a modern predictor of longterm survival. Hepato Pancreato Biliary 2013, 15: 794-802. PMID: 23782341, PMCID: PMC3791119, DOI: 10.1111/hpb.12134.Peer-Reviewed Original ResearchConceptsHepatitis B virusOverall survivalHepatocellular carcinomaViral statusHepatitis C virusGraft survivalLiver transplantationPredictor of poor OSEnd-stage liver disease scoreTime of liver transplantationHepatitis C virus statusLiver Disease scoreTransplantation Network databasePredictors of outcomeAfrican American raceProlonged GSProlonged OSPoor OSRetransplantation rateAntiviral medicationsLongterm survivalB virusC virusMultivariate analysisPoorer GS
2006
Gender differences in quality of HIV care in Ryan White CARE Act-funded clinics
Hirschhorn LR, McInnes K, Landon BE, Wilson IB, Ding L, Marsden PV, Malitz F, Cleary PD. Gender differences in quality of HIV care in Ryan White CARE Act-funded clinics. Women's Health Issues 2006, 16: 104-112. PMID: 16765286, DOI: 10.1016/j.whi.2006.02.004.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overAIDS-Related Opportunistic InfectionsAmbulatory CareAntiretroviral Therapy, Highly ActiveCohort StudiesConfidence IntervalsFemaleHealth Services AccessibilityHealth Services ResearchHumansMaleMedical RecordsMiddle AgedOdds RatioQuality Assurance, Health CareWomen's HealthConceptsRyan White CARE ActPCP prophylaxisHIV careCare ActActive antiretroviral therapy (HAART) useHepatitis C virus statusHIV primary care clinicPneumocystis jiroveci pneumonia prophylaxisC virus statusAntiretroviral therapy useHIV viral suppressionPrimary care clinicsQuality improvement studyDisease prevention effortsQuality of carePneumonia prophylaxisViral suppressionHIV infectionTherapy useCare clinicsClinic characteristicsRecord reviewPap smearVirus statusOutcome measures
2005
Injection Drug Use Is an Independent Risk Factor for Iron Deficiency and Iron Deficiency Anemia Among HIV-Seropositive and HIV-Seronegative Women
Dancheck B, Tang A, Thomas A, Smit E, Vlahov D, Semba R. Injection Drug Use Is an Independent Risk Factor for Iron Deficiency and Iron Deficiency Anemia Among HIV-Seropositive and HIV-Seronegative Women. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2005, 40: 198-201. PMID: 16186738, DOI: 10.1097/01.qai.0000165909.12333.07.Peer-Reviewed Original ResearchConceptsInjection drug useIron deficiency anemiaHepatitis C virus statusFemale injection drug usersC virus statusInjection drug usersDeficiency anemiaDrug useIron deficiencyRisk factorsVirus statusDrug usersMultivariate analysisInjection drug use historyCD4 lymphocyte countHIV-seronegative womenIndependent risk factorHIV-positive womenCross-sectional studyFurther longitudinal studiesNatural history studiesIntravenous Experience (ALIVE) studyDrug use historyHIV-seropositiveLymphocyte count
2004
Association of hypocholesterolaemia with hepatitis C virus infection in HIV‐infected people*
Polgreen P, Fultz S, Justice A, Wagner J, Diekema D, Rabeneck L, Weissman S, Stapleton J. Association of hypocholesterolaemia with hepatitis C virus infection in HIV‐infected people*. HIV Medicine 2004, 5: 144-150. PMID: 15139979, DOI: 10.1111/j.1468-1293.2004.00202.x.Peer-Reviewed Original ResearchConceptsHCV antibody statusHIV exposure categoryTotal cholesterol levelsCholesterol levelsHCV antibodiesHCV infectionAntibody statusExposure categoriesDrug useHepatitis C virus statusHigh-density lipid cholesterolLipid-lowering drug useLow-density lipid cholesterolHepatitis C virus infectionLiver function test resultsLower total cholesterol levelsLipid cholesterolC virus statusHCV-negative subjectsC virus infectionHCV-positive patientsHIV-positive patientsProtease inhibitor useHIV viral loadHIV-negative individuals
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply